BIOADAPTIVES, INC.
BDPT · OTCMCIK 1575142fmd_1PQBX87X5XJCK16SJZXDK6BHS1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Jun 30, 2026, 48 periods
| Line item | FY2014 | FY2015 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 |
| Impairment of real estate | – | – | – | – | – | – | – | 0 | 0 | – |
| Operating income | (2) | (0) | – | (0) | (0) | (1) | (0) | (0) | (1) | (1) |
| Interest expense | – | – | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | (0) | (1) | (0) | – | (0) | (0) | (0) | (0) | (1) |
| Income before taxes | – | – | (1) | (0) | (1) | – | – | – | (1) | (2) |
| Income tax expense | – | – | – | 0 | 0 | 0 | 0 | – | 0 | 0 |
| Net income from continuing operations | – | – | – | (0) | (1) | (1) | (1) | (1) | (1) | (2) |
| Net income | (3) | (0) | (1) | (0) | (1) | (1) | (1) | (1) | (1) | (2) |